logo
Bernstein Keeps Their Sell Rating on A.P. Moeller Maersk A/S (0O77)

Bernstein Keeps Their Sell Rating on A.P. Moeller Maersk A/S (0O77)

Bernstein analyst Alex Irving maintained a Sell rating on A.P. Moeller Maersk A/S (0O77 – Research Report) yesterday and set a price target of DKK9,350.00. The company's shares closed yesterday at DKK11,945.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Irving is a 4-star analyst with an average return of 9.2% and a 59.07% success rate. Irving covers the Industrials sector, focusing on stocks such as Deutsche Lufthansa, DHL Group, and International Consolidated Airlines.
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for A.P. Moeller Maersk A/S with a DKK10,900.00 average price target, which is a -8.75% downside from current levels. In a report released on June 13, Kepler Capital also maintained a Sell rating on the stock with a DKK9,250.00 price target.
The company has a one-year high of DKK13,720.00 and a one-year low of DKK8,730.00. Currently, A.P. Moeller Maersk A/S has an average volume of 776.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Roivant Sciences Stock Bounced Back on Tuesday
Why Roivant Sciences Stock Bounced Back on Tuesday

Yahoo

time31 minutes ago

  • Yahoo

Why Roivant Sciences Stock Bounced Back on Tuesday

Key Points A day after it published its latest set of quarterly earnings, an analyst bumped his price target higher. He also maintained his equivalent of a buy recommendation. 10 stocks we like better than Roivant Sciences › Monday's hangover turned into Tuesday's party for healthcare stock Roivant Sciences (NASDAQ: ROIV). On the back of a modest but meaningful analyst price target hike, investors bid the stock up by nearly 4% following a post-earnings slide the day before. With the Tuesday rise, Roivant handily beat the benchmark S&P 500 index, which bumped 1.1% higher. Boosting the biotech Tuesday's raiser was Leerink Partners prognosticator David Risinger. Well before market open, he added $1 to his Roivant price target for a new level of $18 per share. In doing so, he maintained his recommendation of outperform (read: buy) on the company's stock. According to reports, Risinger's adjustment is based on a change in his forecast for the biotech company's share count. The analyst based this on management's statements about its share repurchase program, which is expected to shave the tally for shares outstanding. As for Roivant's operations, the pundit waxed bullish on the eventual outcome of the company's phase 3 clinical trial of brepocitinib in the treatment of dermatomyositis, a rare inflammatory disease that can affect the muscles and the skin. He's anticipating a readout of the trial to be published in the second half of this year. A first quarter to forget Risinger's continued bullishness on Roivant was a morale-booster for the market, which had traded out of the company's shares after Monday's fiscal first quarter of 2026 earnings release. The company reported significantly lower revenue compared to the same period of 2025, and it flipped to a net loss on the bottom line. Should you buy stock in Roivant Sciences right now? Before you buy stock in Roivant Sciences, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Roivant Sciences wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Roivant Sciences. The Motley Fool has a disclosure policy. Why Roivant Sciences Stock Bounced Back on Tuesday was originally published by The Motley Fool Sign in to access your portfolio

Why Etoro Stock Plummeted Today
Why Etoro Stock Plummeted Today

Yahoo

time31 minutes ago

  • Yahoo

Why Etoro Stock Plummeted Today

Key Points Etoro's second-quarter report came with sales and earnings that beat Wall Street's targets. The fintech company's share price still saw big sell-offs today despite seemingly strong Q2 results. Some investors may have been looking for stronger funded accounts growth, but overall performance was still pretty strong in Q2. 10 stocks we like better than eToro Group › Etoro (NASDAQ: ETOR) stock sank in Tuesday's trading. The company's share price ended the daily session down 8.3% and had been off as much as 9.6% earlier in the session. The sell-offs came despite the S&P 500 index rising 1.1% and the Nasdaq Composite climbing 1.3% on the day. Major indexes notched record highs in Tuesday's session as the latest round of inflation data supported the case for significant interest rate cuts later this year, but Etoro stock still saw big sell-offs following the company's recent quarterly report. The fintech company actually posted second-quarter earnings that came in significantly ahead of the market's expectations, but the stock still got hit with a big sell-off in today's session. Etoro stock got hit hard after earnings Etoro reported non-GAAP (adjusted) earnings per share of $0.56 in the second quarter, beating the average Wall Street analyst estimate's call for adjusted per-share earnings of $0.51 in the period. Meanwhile, the company notched a net contribution of $210 million in the period -- beating the consensus estimate's call for a net contribution of $194.7 million in the period. Etoro's net contribution figure was up 26% year over year, and adjusted net income was up roughly 23% year over year. The company closed out the period with $17.5 billion in assets under its administration, up from 11.3% in the prior-year quarter. Despite some strong momentum in the period, investors were seemingly looking for stronger results -- and the company's share price has tumbled following the quarterly update. What's next for Etoro? While Etoro stock saw a big pullback following the company's Q2 release, the numbers in the report were generally quite strong. The company saw total funded accounts on its platform rise 14% year over year to reach 3.63 million. While some investors seemingly hoped that the company would post strong user growth, overall momentum was still pretty solid. On the heels of today's post-earnings pullback, the stock could be worth a look for risk-tolerant investors. Should you invest $1,000 in eToro Group right now? Before you buy stock in eToro Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and eToro Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Etoro Stock Plummeted Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why Valley National Bank (VLY) Stock Is Up Today
Why Valley National Bank (VLY) Stock Is Up Today

Yahoo

time32 minutes ago

  • Yahoo

Why Valley National Bank (VLY) Stock Is Up Today

What Happened? Shares of regional banking company Valley National Bancorp (NASDAQ:VLY) jumped 4.5% in the afternoon session after the broader market rallied as a favorable inflation report boosted optimism for a potential interest rate cut by the Federal Reserve. The positive market sentiment was triggered by the July Consumer Price Index report, which showed annual inflation holding steady at 2.7%, slightly better than economists had anticipated. This news fueled optimism for a potential interest rate cut from the Federal Reserve, sending major indexes like the S&P 500 and Nasdaq to new all-time highs. Bank stocks, which are highly sensitive to interest rate expectations, joined the broader market rally. While higher interest rates can sometimes increase bank profits, the prospect of a stable or declining rate environment can reduce fears of an economic slowdown, which is generally positive for financial institutions. The shares closed the day at $9.75, up 4.6% from previous close. Is now the time to buy Valley National Bank? Access our full analysis report here, it's free. What Is The Market Telling Us Valley National Bank's shares are not very volatile and have only had 7 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 11 days ago when the stock dropped 3.5% on the news that a surprisingly weak July jobs report and the announcement of sweeping new tariffs fueled fears of an economic slowdown and an impending interest rate cut. The U.S. economy added just 73,000 jobs in July, the weakest gain in over two years, while the unemployment rate rose to 4.2%. This dismal data significantly increased market expectations for a Federal Reserve interest rate cut, with traders now pricing in an 80% probability of a cut in September. Lower interest rates typically harm bank profitability by compressing their net interest margins—the difference between what they earn on loans and pay on deposits. Compounding these worries, the announcement of new tariffs on imports from 92 countries has sparked fears of a global trade war, which could further dampen economic growth and disrupt supply chains, creating a challenging environment for the banking industry. Valley National Bank is up 9.2% since the beginning of the year, but at $9.75 per share, it is still trading 9.6% below its 52-week high of $10.78 from November 2024. Investors who bought $1,000 worth of Valley National Bank's shares 5 years ago would now be looking at an investment worth $1,201. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store